Skip to main content
Article
Requirement of argininosuccinate lyase for systemic nitric oxide production
Nature Medicine
  • Ayelet Erez, Baylor College of Medicine, Houston
  • Sandesh CS. Nagamani, Baylor College of Medicine, Houston
  • Oleg A. Shchelochkov, Baylor College of Medicine, Houston
  • Muralidhar H. Premkumar, Baylor College of Medicine, Houston
  • Philippe M. Campeau Campeau, Baylor College of Medicine, Houston
  • Yuqing Chen, Baylor College of Medicine, Houston
  • Harsha K. Garg, University of Texas - Houston Health Science Center
  • Li Li, Emory University School of Medicine, Atlanta
  • Asad Mian, Aga Khan University
  • Terry K. Bertin, Baylor College of Medicine, Houston
  • Jennifer O. Black, Texas Children’s Hospital, Houston
  • Heng Zeng, Vanderbilt University Medical Center, Nashville
  • Yaoping Tang, University of Texas - Houston Health Science Center
  • Anilkumar K. Reddy, Baylor College of Medicine and The Methodist DeBakey Heart and Vascular Center
  • Marshall Summar, Vanderbilt University Medical Center, Nashville
  • William E. O’Brien, Baylor College of Medicine, Houston
  • David G. Harrison, Emory University School of Medicine, Atlanta
  • William E. Mitch, Baylor College of Medicine, Houston
  • Juan C. Marini, Baylor College of Medicine
  • Judy L. Aschner, Vanderbilt University Medical Center, Nashville
  • Nathan S. Bryan, University of Texas - Houston Health Science Center
  • Brendan Lee, Howard Hughes Medical Institute, Houston
Publication Date
1-1-2011
Document Type
Article
Disciplines
Abstract

Nitric oxide (NO) is crucial in diverse physiological and pathological processes. We show that a hypomorphic mouse model of argininosuccinate lyase (encoded by Asl) deficiency has a distinct phenotype of multiorgan dysfunction and NO deficiency. Loss of Asl in both humans and mice leads to reduced NO synthesis, owing to both decreased endogenous arginine synthesis and an impaired ability to use extracellular arginine for NO production. Administration of nitrite, which can be converted into NO in vivo, rescued the manifestations of NO deficiency in hypomorphic Asl mice, and a nitric oxide synthase (NOS)-independent NO donor restored NO-dependent vascular reactivity in humans with ASL deficiency. Mechanistic studies showed that ASL has a structural function in addition to its catalytic activity, by which it contributes to the formation of a multiprotein complex required for NO production. Our data demonstrate a previously unappreciated role for ASL in NOS function and NO homeostasis. Hence, ASL may serve as a target for manipulating NO production in experimental models, as well as for the treatment of NO-related diseases.

Comments

This work was published before the author joined Aga Khan University.

Citation Information
Ayelet Erez, Sandesh CS. Nagamani, Oleg A. Shchelochkov, Muralidhar H. Premkumar, et al.. "Requirement of argininosuccinate lyase for systemic nitric oxide production" Nature Medicine Vol. 17 Iss. 12 (2011) p. 1619 - 1626
Available at: http://works.bepress.com/asad_mian/23/